|
Home | Medical-Newswire.Com:
|
(Medical-NewsWire.com, December 10, 2018 ) Immunohistochemistry Market Overview
Immunohistochemistry is a staining procedure done on a new or stored cancer tissue which is removed during biopsy. IHC is used to identify if the cancer cells have hormone receptors on their surface. IHC is mainly used for diagnosis of cancers, especially tumour antibodies.
Request for Sample @ https://www.marketdataforecast.com/market-reports/immunohistochemistry-market-2855/request-sample
Rising incidences of cancer and rising geriatric population around the world are some main drivers for the growth of the immunohistochemistry market. Other factors which fuel the market growth are rising expenditure on healthcare and improving healthcare infrastructure thus leading to more and more number of hospitals and the diagnostic laboratories day by day.
Immunohistochemistry Market Forecast Report (2018-2023)
Global Immunohistochemistry Market worth was USD 1.75 billion in 2018 and estimated to be growing at a CAGR of 7.4%, to reach USD 2.5 Billion by 2023.
Browse Report Brief and TOC @ https://www.marketdataforecast.com/market-reports/immunohistochemistry-market-2855/
Immunohistochemistry Market Segmentation
Product
Introduction
Antibodies
Reagents
Equipment
Kits
Introduction
Application
Diagnostics
Drug testing
End Users
Introduction
Hospitals and Diagnostics Laboratories
Research Institutes
The immunohistochemistry antibody segment accounted for the large share of immunohistochemistry market, by product while hospitals and diagnostic laboratories segment lead the market in end users.
Immunohistochemistry Geographical Market Segmentation
On the basis of region, the global market is classified into North America, Asia-Pacific, Europe, Latin America and Middle-East and Africa. The market is led by North America because of advancement in the biotech market and commercialization. However, Asia-Pacific is expected to have high CAGR during the forecasting period.
Key Developments in the Market
Hoffman-La Roche AG ordered a share of 22.1% of the global immunohistochemistry market in 2015. The company is a major immunohistochemistry product manufacturer and supplies its products to hospitals, pharmaceutical companies, research laboratories, and contract research organizations.
Roche mainly focuses on achievements as its key business strategy. In line with this strategy, in August 2015, Roche obtained GeneWEAVE BioSciences, Inc. (U.S.), a privately held company focused on modern clinical microbiology diagnostics solutions.
In December 2014, the company Obtained GeneWEAVE BioSciences, Inc. (U.S.), a privately held company focused on modern clinical microbiology diagnostics solutions, and Ariosa Diagnostics, Inc. (U.S.), a molecular diagnostics testing service provider that provides a high targeted and accurate non-invasive prenatal testing (NIPT) service through its CLIA laboratory using the cell-free DNA (cfDNA) technology.
Buy now @ https://www.marketdataforecast.com/cart/buy-now/immunohistochemistry-market-2855/
Major Players:
Major players in the current market are:
Hoffmann-La Roche AG
Danaher Corporation
Agilent Technologies, Inc.
Thermo Fisher Scientific Inc
Merck Millipore
Bio-Rad Laboratories, Inc
PerkinElmer, Inc
Abcam plc
Cell Signaling Technology, Inc
Bio SB Inc.
Customize Report @ https://www.marketdataforecast.com/market-reports/immunohistochemistry-market-2855/customize-report
About Us
Market Data Forecast is dedicate working in the areas of market research, business intelligence and consulting. We have a great experience in research and consulting for different business domains to cater the needs of both individual and corporate clients.
For more information:
Abhishek Shukla
Sales Manager at Market Data Forecast
Email: abhishek@marketdataforecast.com
Tel: +1-888-702-9626
Website: www.marketdataforecast.com
Market Data Forecast.
Abhishek Shukla
+1-888-702-9626
abhishek@marketdataforecast.com
Source: EmailWire.Com 
Source: EmailWire.com
|
|
|
|
